Impaired value-based decision-making in Parkinson's disease apathy.

Area of Science:

• Neuroscience
• Cognitive Science
• Neurology

Background:

• Apathy is a common, disabling Parkinson's disease complication linked to prefrontal cortex and brainstem neuromodulator dysfunction (dopamine, serotonin, noradrenaline).
• Neuromodulators influence motivated decision-making, including value encoding and exploration vs. exploitation strategies.
• Previous research suggests these neuromodulators are crucial for goal-directed behavior, which is impaired in apathy.

Purpose of the Study:

• To investigate the hypothesis that apathy in Parkinson's disease is associated with impaired value-based learning.
• To examine decision-making processes and neural correlates in Parkinson's disease patients with and without apathy.

Main Methods:

• A four-armed restless bandit reinforcement learning task was administered to 75 participants (53 Parkinson's disease patients, 22 controls).
• Computational modeling analyzed choice behavior to assess learning and decision-making strategies.
• Functional MRI (fMRI) was used to examine brain activity in 59 participants during task performance.

Main Results:

• Parkinson's disease patients with apathy showed impaired ability to select the highest value option and were indifferent to learned option values.
• Apathy severity correlated with reduced exploitation of high-value options and decreased perseveration.
• fMRI revealed diminished ventromedial prefrontal cortex activation in Parkinson's disease, more pronounced in apathy.
• Parkinson's patients without apathy exhibited increased thalamo-cortical network activation, potentially a compensatory mechanism.

Conclusions:

• Apathy in Parkinson's disease is characterized by deficits in value-based learning and decision-making, including reward insensitivity.
• Neural activity in the thalamus, dorsal anterior cingulate cortex, and anterior insula may play a compensatory role in mitigating apathy symptoms.
• Understanding these neural mechanisms can inform targeted interventions for apathy in Parkinson's disease.